Amlodipine Besylate Tablet
Product Images NDC 69097-127

6 FDA label images from Cipla Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 69097-127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 01

Dc48db65 Ee80 4852 A3aa A23ec74f4416 01
Chemical structure of amlodipine besylate, showing its molecular framework with atoms and bonds, including a chlorine atom, methyl groups, an amino group, and ester functional groups as part of the compound.*
FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 02

Dc48db65 Ee80 4852 A3aa A23ec74f4416 02
A Kaplan-Meier event rate curve comparing Amlodipine versus Placebo over 24 months. The plot shows event rates on the y-axis and time in months on the x-axis, with separate lines labeled for Amlodipine and Placebo. Key statistics including P-value, Hazard Ratio, and 95% Confidence Interval are displayed in an inset box. The number of subjects at risk is shown along the x-axis.*
FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 03

Dc48db65 Ee80 4852 A3aa A23ec74f4416 03
A forest plot showing hazard ratios with 95% confidence intervals for various patient subgroups comparing Amlodipine versus Placebo. The subgroups include overall patients, age groups under and over 65, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI stent strata. The x-axis represents hazard ratio values from 0.0 to 2.0, with a reference line at 1.0.*
FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 04

Dc48db65 Ee80 4852 A3aa A23ec74f4416 04
Label for Amlodipine Besylate Tablets USP 2.5 mg by Cipla USA Inc. The label indicates a package of 90 oral tablets with directions for storage at 20° to 25°C and dispensing with patient leaflet. It includes manufacturer details, barcode, and space for batch information printing such as serial number, expiry, and lot.*
FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 05

Dc48db65 Ee80 4852 A3aa A23ec74f4416 05
Label for Amlodipine Besylate Tablets USP 5 mg by Cipla USA Inc. The label indicates 90 tablets per container, with storage instructions, manufacturer details, and a barcode. It highlights that each tablet contains 5 mg of Amlodipine and advises pharmacists to dispense with the patient leaflet. Space is reserved for batch overprinting including serial number, expiry, and lot details.*
FDA Label Image

Dc48db65 Ee80 4852 A3aa A23ec74f4416 06

Dc48db65 Ee80 4852 A3aa A23ec74f4416 06
Label for Amlodipine Besylate Tablets, USP 10 mg, oral tablets manufactured by Cipla Ltd. and labeled for Cipla USA Inc. The label includes the NDC 69097-128-05, a count of 90 tablets, and storage instructions to keep the product between 20°C to 25°C with protection from light and moisture. It also advises pharmacists to dispense with the patient leaflet.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.